- Training
- 90 Minutes
United States
- Training
- 120 Minutes
Global
- Training
- 90 Minutes
Global
- Newsletter
- November 2024
- 4 Pages
Global
From €198EUR$200USD£164GBP
- Report
- February 2022
- 64 Pages
United States
From €2464EUR$2,495USD£2,050GBP
- Report
- November 2024
- 80 Pages
Denmark, Finland, ... Denmark, Finland, Iceland, Norway, Sweden
From €871EUR$913USD£700GBP
- Report
- November 2024
- 1510 Pages
Global
From €1182EUR$1,238USD£950GBP
- Report
- November 2024
- 537 Pages
United Kingdom
From €496EUR$520USD£399GBP
- Report
- October 2024
- 1443 Pages
Europe
From €995EUR$1,043USD£800GBP
- Report
- December 2022
- 69 Pages
Global
From €1975EUR$2,000USD£1,643GBP
- Report
- December 2022
- 99 Pages
Global
From €1975EUR$2,000USD£1,643GBP
- Report
- November 2022
- 246 Pages
Global
From €1975EUR$2,000USD£1,643GBP
- Report
- October 2022
- 90 Pages
Global
From €1975EUR$2,000USD£1,643GBP
- Report
- May 2022
- 226 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- May 2022
- 47 Pages
Global
From €1975EUR$2,000USD£1,643GBP
- Report
- May 2022
- 84 Pages
Global
From €1975EUR$2,000USD£1,643GBP
- Report
- May 2022
- 39 Pages
Global
From €1975EUR$2,000USD£1,643GBP
- Report
- May 2022
- 51 Pages
Global
From €1975EUR$2,000USD£1,643GBP
- Report
- May 2022
- 38 Pages
Global
From €1975EUR$2,000USD£1,643GBP
- Report
- May 2022
- 41 Pages
Global
From €2469EUR$2,500USD£2,054GBP
The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs.
The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more